FDA ok's once-nightly med for narcolepsy
, compared with placebo, extended-release sodium oxybate demonstrated statistically significant reported for all doses of the drug combined were nausea, dizziness,.
, compared with placebo, extended-release sodium oxybate demonstrated statistically significant reported for all doses of the drug combined were nausea, dizziness,Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Alaska News Nightly: Monday, May 1, 2023Tonight on Alaska News Nightly: Lawmakers discuss changing the way oil companies are taxed. Plus, Alaska State Troopers will soon begin using body-worn cameras. Listen here:
Read more »
US FDA declines to approve Ascendis' hormone disorder therapyAscendis Pharma A/S said on Monday the U.S. Food & Drug Administration had declined to approve the Danish drugmaker's experimental therapy to treat adult patients with a hormone disorder called hypoparathyroidism, citing concerns linked to manufacturing control of the drug and device combination.
Read more »
The Newest FDA-Approved Neuromodulator Will Get Rid of 11-Lines for Six MonthsThis new Botox alternative promises results that last twice as long as its competitors. So—what do actual dermatologists think?
Read more »
Xelstrym to Launch Soon: New FDA-Approved ADHD Stimulant PatchXelstrym is the first FDA-approved transdermal amphetamine patch to treat pediatric and adult patients with ADHD. It is expected to launch later this year.
Read more »
Biden courts son of Philippine dictator he once opposedFerdinand Marcos Jr. was elected president of the Philippines last year. Now he hopes to reverse his family's status as international pariahs.
Read more »